These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18358752)

  • 1. Prevalence of cardiovascular risk factors in patients with type 1 diabetes in end-stage renal disease: changes in the trend from 1999 to 2006.
    Rueda SF; Fernández C; Nicolau J; Ricart MJ; Esmatjes E
    J Diabetes Complications; 2009; 23(5):317-22. PubMed ID: 18358752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
    Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
    Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.
    Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A
    J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compliance with the 2002 consensus document of the Spanish Society of Nephrology for the control of diabetic nephropathy in Catalonia (ECCODIAB)].
    Fontseré N; Bonal J; Torres F; de las Cuevas X; Fort J
    Nefrologia; 2006; 26(6):679-87. PubMed ID: 17227245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated haemoglobin and the incidence of end-stage renal disease in diabetics.
    Oh SW; Kim YC; Koo HS; Jin DC; Na KY; Chae DW; Kim S; Chin HJ
    Nephrol Dial Transplant; 2011 Jul; 26(7):2238-44. PubMed ID: 21098657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics?
    Lacigová S; Safránek P; Cechurová D; Krcma M; Vísek J; Jankovec Z; Zourek M; Haladová I; Rusavý Z
    Wien Klin Wochenschr; 2007; 119(9-10):303-8. PubMed ID: 17571235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.
    McFarlane SI; Jacober SJ; Winer N; Kaur J; Castro JP; Wui MA; Gliwa A; Von Gizycki H; Sowers JR
    Diabetes Care; 2002 Apr; 25(4):718-23. PubMed ID: 11919131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors and cardiovascular disease in patients with type 1 diabetes and end-stage renal disease candidates for kidney-pancreas transplantation: Trends from 1999 to 2017.
    Ruiz S; Amor AJ; Pané A; Molina-Andujar A; Montagud-Marrahi E; Ventura-Aguiar P; Ferrer-Fàbrega J; Esmatjes E
    Diabetes Res Clin Pract; 2020 May; 163():108135. PubMed ID: 32259612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
    Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
    Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).
    Schwab KO; Doerfer J; Hecker W; Grulich-Henn J; Wiemann D; Kordonouri O; Beyer P; Holl RW;
    Diabetes Care; 2006 Feb; 29(2):218-25. PubMed ID: 16443863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
    Busch M; Franke S; Stein G; Wolf G;
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
    Cederholm J; Eliasson B; Nilsson PM; Weiss L; Gudbjörnsdottir S;
    Diabetes Res Clin Pract; 2005 Mar; 67(3):258-66. PubMed ID: 15713359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
    Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
    Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.